Calcium elenolate, an antiviral agent which inhibits reverse transcriptases, inhibits the growth of chicken embryo fibroblast cells, as well as Echerichia coli and Bacillus subtilis strains. The drug in vitro inhibits E. coli deoxyribonucleic acid (DNA) polymerase II and DNA polymerase III holoenzyme, as well as several unrelated enzymes. The usual DNA polymerase assay components, with the exception of spermidine, have no effect on the observed inhibition. Inhibition of DNA polymerase II by the drug appears to be due to a direct and irreversible effect on the enzyme. However, DNA synthesis in E. coli is no more susceptible to the drug than is the increase in cell mass. These results suggest that calcium elenolate is an inhibitor of rather low specificity.
Calcium elenolate, a monoterpene which is isolated from aqueous extracts of the olive plant (Olea europa) after mild acid hydrolysis (1, 14) , has been shown to be virucidal in vitro for a number of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) viruses (15) . It also reduces the yields of virus from hamsters infected with parainfluenza 3 virus (16) and has minimal toxicity when administered to animals (2). Calcium elenolate inhibits the RNA-dependent DNA polymerases (reverse transcriptases) of both Moloney and Rauscher leukemia viruses, 50% inhibition occurring at calcium elenolate concentrations of 20 ug/ml (75 gM) (5) . The drug does not appear to react with nucleosides or with DNA or RNA (5, 15) . It has been suggested that the drug acts directly against the reverse transcriptases (5). The drug can be inactivated by prior incubation with 2-M equivalents of the amino acids glycine, lysine, cysteine, or histidine, but not with other amino acids (15) . Inactivation requires the presence of a free amino group. However, the drug does not inhibit Escherichia coli RNA polymerase or DNA polymerase I at drug concentrations as high as 200 ,ug/ml (5) . Recently the structure of elenolic acid (10) and the total synthesis of DL-methyl elenolate have been reported (6) .
We decided to determine if the drug inhibited E. coli DNA polymerase II or Ill since reverse transcriptases resemble these enzymes in a number of properties (7) . A specific inhibitor of either E. coli enzyme might prove useful in elucidating the physiological roles of these enzymes in the cell. However, we report that both enzymes are inhibited to a similar extent and, moreover, further studies indicate that the drug is rather nonspecific.
MATERIALS AND METHODS

Materials. Tissue culture dishes were from Falcon
Plastics. Powdered Dulbecco modified Eagle medium, tryptose phosphate broth, calf serum, and chicken serum were obtained from Grand Island Biochemical Co.
[3H ]thymine, 7 .0 Ci/mmol, was purchased from Schwarz/Mann. [3H ideoxythymidine 5'-triphosphate, 50 Ci/mmol, was obtained from New England Nuclear. Calf thymus DNA (type V) was obtained from Sigma and digested with pancreatic deoxyribonuclease (DNase) I (Worthington, EC 3.1.4.5) to give maximal DNA polymerase III activity (18) . Calcium elenolate, lot 9426-JHF-2, was the generous gift of the Upjohn Company, Kalamazoo, Mich. When dissolved in water at 1 to 10 mg/ml and stored frozen, the drug appeared stable for at least 2 months with repeated freezing and thawing.
Growth of bacteria. The E. coli strains W3110
(thyA36 and dra-2) and D110 (polAl, endA-, thyA36 and dra-2) were obtained from the E. [8] ) and indicated concentrations of calcium elenolate. Incubations were for 30 min at 37 C; nucleotide incorporation into acid-insoluble product was measured as previously described (11) . Crude extracts of DNA polymerase III holoenzyme (fraction 1) were prepared as described by Wickner and Kornberg (19) Incubations were for 5 min at 30 C; nucleotide incorporation into acid-soluble product was measured as previously described (11) . DNA polymerase II activity is not detectable in crude extracts in this assay (9) .
RESULTS
Spectrum of enzyme inhibition. As shown in Fig. 1 Thus the apparent differences in the susceptibility of the two enzymes cannot be explained by the differences in the enzyme assays.
Inhibition of DNA polymerase II activity by calcium elenolate could not be overcome by increasing the concentration of DNA, deoxyribonucleoside triphosphates, or magnesium, but could be overcome by increasing the concentration of enzyme (Table 1) . Thus inhibition appears to be directed against the enzyme itself. Furthermore, the inhibition of DNA polymerase II by calcium elenolate appeared to be irreversible (Table 1) . DNA polymerase II was exposed to 500 Ag of calcium elenolate per ml for 5 min at 37 C and then diluted 30-fold into the standard assay mixture, which contained no cal- Mg/ml, a concentration that gave negligible inhibition of DNA polymerase II (Fig. 1) . However, in this experiment, DNA polymerase II was strongly inhibited compared to a control exposed to water, indicating that the effects of exposure to 500,Mg of calcium elenolate per ml were irreversible.
The effect of calcium elenolate on the activity of several other enzymes is also shown in Fig. 1 . Although pancreatic DNase I was only slightly inhibited at high drug concentrations, lysozyme and micrococcal nuclease both were more susceptible to inhibition by calcium elenolate than DNA polymerase II. Indeed micrococcal nuclease, which was 50% inhibited at 2,Mg/ml (7.5 ,MM), was 10-fold more susceptible to the drug than are viral reverse transcriptases (5) .
In vivo target of inhibition in E. coli. Since DNA polymerase III, which is essential for DNA replication in E. coli (3, 12), was inhibited by calcium elenolate, we wanted to determine if DNA synthesis in E. coli was preferentially inhibited by calcium elenolate in vivo. Preliminary experiments (data not shown) had established that the growth of B. subtilis WB746, as well as E. coli W3110, was inhibited by calcium elenolate. Thus we examined the effects of calcium elenolate on an exponentially growing culture of E. coli (Fig. 2) . Figure 2A is the control and indicates that the cells were in balanced exponential growth as indicated by the parallel increase in all parameters. Figure 2B shows the effects of 200 Mg (0.75 mM) of calcium elenolate per ml. The drug appeared bacteriostatic at this concentration since all parameters changed in parallel from a 60-min doubling time to a 75-min doubling time after 20 min of exposure to the drug. Note that even at a drug concentration which had only a small effect on the growth of this strain, DNA synthesis did not appear to be more susceptible to inhibition than was the increase in cell mass. Figure 2C shows the effects of 500 ug (1.88 mM) of calcium elenolate per ml. DNA synthesis, cell division, and cell growth ceased within 20 min of exposure to the drug. The drug appeared to be highly bactericidal at this concentration since the viable cell count dropped dramatically after the addition of the drug.
Effects of calcium elenolate on chicken embryo fibroblasts. It had been reported that calcium elenolate at a concentration of 200 Mg/ml is nontoxic to mouse embryo fibroblast cells in culture (5) . We have shown that the drug at this concentration slows the growth rate of E. coli and inhibits a number of enzymes in vitro. Since calcium elenolate can be inactivated by amino acids (15) , which are present in tissue culture medium, we have examined the effects of the drug on chicken embryo fibroblast cells in culture under several experimental conditions (Table 2) . When the cells were washed with phosphate-buffered saline to remove amino acids in the medium and then exposed to calcium elenolate in phosphate-buffered saline for 30 min, a drug concentration of 500 Ag/ml appeared to be toxic whereas 200 Mg/ml dramatically slowed the rate of growth. A drug concentration of 50 ,ug/ml had no effect on the growth rate. However, as shown in Table 2 , the effects of calcium elenolate on chicken embryo fibroblast cells depended strongly on the medium and the length of exposure to the drug. Even under the mildest conditions employed (30-min exposure in growth medium), the growth rate was still slightly inhibited at 200 ,g of calcium elenolate per ml. DISCUSSION These studies with calcium elenolate have shown that the drug inhibits the growth of E. coli and B. subtilis strains. The drug inhibits E. coli DNA polymerase II and DNA polymerase III holoenzyme in vitro. The small difference in apparent susceptibility of the enzymes cannot be explained by differences in the assay conditions of the enzyme, but may reflect differences in the purity of the enzyme preparations since the drug appears to react directly and irreversibly with DNA polymerase II and inhibits several unrelated enzymes. Calcium elenolate does not appear to function as a sulfhydryl-blocking agent (5, 15) , but is inactivated by incubation with amino acids (15) and spermidine. The drug appears to react with free amino groups (15) .
Although DNA polymerases II and III are inhibited by calcium elenolate in vitro, DNA synthe- sis in E. coli is no more susceptible to the drug than is the increase in cell mass. These observations suggest that the primary effect of calcium elenolate in E. coli is inhibition of growth, probably by covalent reaction with free amino acids and proteins. Calcium elenolate also affects the rate of growth of chicken embryo fibroblast cells in culture, the extent of the effect depending on the drug concentration and the experimental conditions. Our results suggest that care must be exercised when the antiviral effects (5, 15) of calcium elenolate are examined, since not only are a number of enzymes likely to be inhibited, but also the tissue culture cells themselves may be affected by the drug, depending on its concentration and the experimental protocol.
Calcium elenolate seems to be a drug of rather low specificity. Since it apparently reacts only with the amino group of certain amino acids (15) , it seems reasonable to postulate that the drug inhibits the various enzymes by reacting with the e-amino group of exposed lysine residues and the exposed N-terminal amino group of polypeptide chains. The variation in the susceptibility of enzymes (and cells) may reflect the number of such residues that are exposed to the drug and the effect of their modification on enzymatic activity. Consistent with this model is the observation that bovine serum albumin is required at bovine serum albumin to drug molar ratios of at least 2 to 1 to prevent inhibition of micrococcal nuclease by 2 ,ug of calcium elenolate per ml (data not shown).
Thus the drug appears to react with bovine serum albumin, contrary to published results (5) , but only at a small number of residues per protein molecule.
Although these results suggest that calcium elenolate has rather low specificity, the drug may still prove useful as a probe of cellular and viral surfaces and of protein structure.
